
MSD's capsule-based treatment for Covid-19 is far less effective than originally thought.
A new, larger patient study reveals that the pill reduced hospitalizations and deaths associated with Covid-19 by 30 percent, compared to a previous 48 percent, Bloomberg News reports.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app